EMAIL TO A FRIEND COMMENT

 

Nationwide Recall of Morphine Sulfate Injection That May Contain More Than Intended Fill Volume


Hospira, Inc. (NYSE: HSP), announced it is initiating a user level recall of one lot of Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1258-30, due to a customer report of two Carpuject syringes containing more than the 1 mL labeled fill volume.

 

Opioid pain medications such as morphine have life-threatening consequences if overdosed. Those consequences can include respiratory depression (slowed breathing or suspension of breathing), and low blood pressure.

 

The affected product is a prefilled glass cartridge for use with the Carpuject™ Syringe system. The affected lot number is 10830LL. The expiration date is April 1, 2013. Morphine Sulfate Carpujects 4 mg/mL are packaged in Slim-Pak® tamper detection packages with each box containing 10 Carpujects (NDC 0409-1258-30). 

 

The affected lot was distributed in January 2012. It was initially distributed to wholesalers and a limited number of hospitals in Arizona, Colorado, Hawaii, Illinois, Indiana, Michigan, Minnesota, Ohio, Texas and Virginia. 

 

See the FDA Recall

 

 

REPRINTS & PERMISSIONS COMMENT